Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Traws Pharma, Inc. (NASDAQ: TRAW)
TRAW Stock Predictions and Ratings
WSX Rating:
SELL
WSX Forecast (1yr):
-4.50%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
175.90%
TRAW Stock Analysis
TRAW
PE Ratio:
TRAW
PEG Ratio:
Not Available
TRAW
Forward EPS Growth (12 month):
0.00%
TRAW
PS Ratio:
4.8
TRAW
PSG Ratio:
Not Available
TRAW
Forward Revenue Growth (12 month):
0.00%
TRAW Articles
No data was found